Come up with a name for your new list and we'll add to it:
Stemline Therapeutics raised a round of funding on April 15, 2008. Investors include
Pequot Capital Mangement.
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology therapeutics that target cancer stem cells (CSCs) as well as the tumor bulk. Among Stemline's drug candidates ar…